Oxygen radicals and other radical species are toxic to cells, most often by damaging membrane lipids and DNA. Cells have multiple levels of antioxidant defenses, and superoxide dismutase is the first level of defense against superoxide radicals. The notion that a gradual decrease in these defenses might play a role in aging or neurodegenerative diseases has been considered for years, but has remained controversial. The recent discovery of mutations in the gene for Cu/Zn superoxide dismutase (SOD1) in familial ALS provides the first good evidence that a specific defect in antioxidant defenses could be responsible for a neurodegenerative disease. To determine whether decreased SOD activity could contribute to motor neuron loss, we intend to model the chronic loss of SOD1 in spinal cord organotypic cultures and then to use this model to investigate various neuroprotective strategies: (1) Toxicity Model: To develop a model of chronic oxidative toxicity in organotypic spinal cord cultures. Is chronic inhibition of superoxide dismutase toxic to motor neurons in spinal cord: We will develop a rodent spinal cord organotypic culture system, then define susceptibility of large cholinergic anterior horn cells to acute and chronic exposure to SOD1 inhibition. Significance: Creation of in vitro models allows for experimental control and pharmacologic manipulation that is impossible in patients. (2) Using a model of chronic oxidative injury, can motor neuron loss be prevented by antioxidants and other potential neuroprotectants: Significance: Current knowledge of biochemical cascades operant in programmed cell death suggest that neuronal toxicity induced by oxidative stress might be blocked with both antioxidants and neurotrophic factors. These studies will provide data on which class of drugs might be most beneficial and specific to the prevention of motor neuron death in ALS. (3) The Bcl-2 family of natural antioxidants: Can the bcl-2 proto- oncogene protect against the neurotoxicity of chronic oxidative stress? Organotypic spinal cord cultures prepared from transgenic mice in which Bcl-2 has either been knocked out or over-expressed will be used to study the role of this putative mediator of antioxidant pathways as a natural antioxidant or neuroprotectant. Significance: Bcl-2 is a unique endogenous protein that can block apoptotic death. As a natural antioxidant, it could function to prevent chronic neural degeneration due to oxidative stress. (4) Specificity: Does glutamate toxicity participate in the selective targeting of motor neurons in models of oxidative stress? Significance: Selective cell death is central to understanding the pathogenesis of ALS as well as other neurodegenerative processes. These experiments will test the overall hypothesis that chronic excess oxygen radical play an important pathophysiologic role in motor neuron death. If this were true it would have fundamental consequences for our understanding on chronic oxidative insults in neural degenerative disorders and aging, and how to approach them neuropharmacologically.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG012992-02
Application #
5205002
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Zhang, Ke; Donnelly, Christopher J; Haeusler, Aaron R et al. (2015) The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature 525:56-61
Matthews, Christopher C; Fishman, Paul S; Wittenberg, George F (2014) Tetanus toxin reduces local and descending regulation of the H-reflex. Muscle Nerve 49:495-501
van Zundert, Brigitte; Peuscher, Marieke H; Hynynen, Meri et al. (2008) Neonatal neuronal circuitry shows hyperexcitable disturbance in a mouse model of the adult-onset neurodegenerative disease amyotrophic lateral sclerosis. J Neurosci 28:10864-74
Ranganathan, Srikanth; Williams, Eric; Ganchev, Philip et al. (2005) Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis. J Neurochem 95:1461-71
Ryu, Hoon; Smith, Karen; Camelo, Sandra I et al. (2005) Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice. J Neurochem 93:1087-98
Maxwell, Michele M; Pasinelli, Piera; Kazantsev, Aleksey G et al. (2004) RNA interference-mediated silencing of mutant superoxide dismutase rescues cyclosporin A-induced death in cultured neuroblastoma cells. Proc Natl Acad Sci U S A 101:3178-83
Ulug, Aziz M; Grunewald, Thomas; Lin, Michael T et al. (2004) Diffusion tensor imaging in the diagnosis of primary lateral sclerosis. J Magn Reson Imaging 19:34-9
Klivenyi, Peter; Kiaei, Mahmoud; Gardian, Gabrielle et al. (2004) Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurochem 88:576-82
Pasinelli, Piera; Belford, Mary Elizabeth; Lennon, Niall et al. (2004) Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron 43:19-30
Klivenyi, Peter; Calingasan, Noel Y; Starkov, Anatoly et al. (2004) Neuroprotective mechanisms of creatine occur in the absence of mitochondrial creatine kinase. Neurobiol Dis 15:610-7

Showing the most recent 10 out of 89 publications